Contact |
You are now leaving the Averitas Pharma, Inc. website and will be redirected to a site intended for an international audience. Please be aware that the content, products, and services on the international site may differ from those on our U.S. site and may not be approved for a U.S. audience.
Click "Continue" if you wish to proceed to the international site, or "Cancel" to stay on the current page.
We approach pain as a disease in urgent need of a solution, rather than a mere symptom. Our empathy for patients, and our shared sense of mission and purpose, are what inspire us.
people live with unresolved diabetic nerve pain despite trying other first-line treatments.
Diabetic peripheral neuropathy (DPN) of the feet occurs if nerves are damaged as a result of diabetes. Damaged nerves cannot correctly transmit signals from the periphery to the central nervous system, causing the signals to be exaggerated and resulting in debilitating pain.
of shingles patients aged ≥50 years develop PHN.
Postherpetic neuralgia (PHN), also known as post-shingles nerve pain, occurs if nerves are damaged due to a previous herpes zoster infection, commonly known as shingles. Damaged nerves cannot correctly transmit signals from from the periphery to the central nervous system, which can cause chronic and debilitating pain.
We are proud of our heritage and honor it by working tirelessly toward a world free of pain.
Our people are the key to our success. We are known as entrepreneurs, pioneering thinkers and innovators.
LEARN MORE
Come see how drawing on our collective strengths helps us deliver on our ambitious goals.
LEARN MOREYou are now leaving the Averitas Pharma, Inc. website and will be redirected to a site intended for an international audience. Please be aware that the content, products, and services on the international site may differ from those on our U.S. site and may not be approved for a U.S. audience.
Click "Continue" if you wish to proceed to the international site, or "Cancel" to stay on the current page.
We are proudly building on the 75-year legacy of Grünenthal, a global privately held healthcare company that has been working tirelessly toward a world free of pain by approaching pain as a disease in urgent need of a solution, rather than a mere symptom.